{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:27:16Z","timestamp":1792686436925,"version":"4.5.0"},"reference-count":30,"publisher":"Termedia Sp. z.o.o.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reumatologia"],"published-print":{"date-parts":[[2019,9,24]]},"abstract":"<jats:p>Intravesical instillation of bacillus Calmette-Guerin (BCG) after transurethral cancer resection is an approved part of the management of non-muscle invasive bladder cancer (NMIBC). The onset of polymyalgia rheumatica (PMR) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) following this immunotherapy is anecdotal. We report the case of a 69-year-old male patient suffering from boxing-glove swelling of the hand associated with bilateral pain, aching and stiffness in the shoulders and pelvic girdles, which occurred after a cycle of six intravesical instillations of BCG. Polymyalgia rheumatica associated with RS3PE was diagnosed, prednisone therapy started and definitively stopped after 13 months. During a 16-year follow-up, no alternative diagnosis was possible. The role of genetic factors and of the senescence of the immune system is discussed. According to our best knowledge, this is the first case report of PMR associated with RS3PE following intravesical instillation of BCG.<\/jats:p>","DOI":"10.5114\/reum.2019.87617","type":"journal-article","created":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T10:39:27Z","timestamp":1567679967000},"page":"249-252","source":"Crossref","is-referenced-by-count":4,"title":["Polymyalgia rheumatica and remitting seronegative symmetrical synovitis with pitting edema following intravesical instillation of bacillus Calmette-Guerin"],"prefix":"10.5114","volume":"57","author":[{"given":"Ciro","family":"Manzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3061","published-online":{"date-parts":[[2019,8,31]]},"reference":[{"key":"ref-777091","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/acr.23132","article-title":"Epidemiology of polymyalgia 3rheumatica 2000-2014 and examination of incidence and survival trends over 45 years: a population-based study","volume":"69","author":"Raheel S","year":"2017","unstructured":"Raheel S, Shbeeb I, Crowson CA, Matteson EL. (2017). Epidemiology of polymyalgia 3rheumatica 2000-2014 and examination of incidence and survival trends over 45 years: a population-based study Arthritis Care Res. 69: 1282-1285.","journal-title":"Arthritis Care Res"},{"key":"ref-777092","first-page":"S9","article-title":"Epidemiology of polymyalgia rheumatica","volume":"18","author":"Cimmino MA","year":"2000","unstructured":"Cimmino MA, Zaccaria A. (2000). Epidemiology of polymyalgia rheumatica Clin Exp Rheumatol. 18: S9-11.","journal-title":"Clin Exp Rheumatol"},{"key":"ref-777093","first-page":"593","article-title":"Diagnosis of polymyalgia rheumatica usually means a favourable outcome for your patient","volume":"145","author":"Milchert M","year":"2017","unstructured":"Milchert M, Brzosko M. (2017). Diagnosis of polymyalgia rheumatica usually means a favourable outcome for your patient Indian J Med Res. 145: 593-600.","journal-title":"Indian J Med Res"},{"key":"ref-777094","first-page":"221","article-title":"Polymyalgia Rheumatica (PMR): Diagnostic and therapeutic issues of an apparently straightforward disease","volume":"108","author":"Manzo C","year":"2017","unstructured":"Manzo C, Camellino D. (2017). Polymyalgia Rheumatica (PMR): Diagnostic and therapeutic issues of an apparently straightforward disease Recenti Prog Med. 108: 221-231.","journal-title":"Recenti Prog Med"},{"key":"ref-777095","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/ard.2004.025296","article-title":"A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica","volume":"64","author":"Bird HA","year":"2005","unstructured":"Bird HA, Leeb BF, Montecucco CM, et al. (2005). A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica Ann Rheum Dis. 64: 626-629.","journal-title":"Ann Rheum Dis"},{"key":"ref-777096","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/rheumatology\/key431","article-title":"Polymyalgia rheumatica with normal values of both erythrocyte sedimentation rate and C-reactive protein concentration at the time of diagnosis","volume":"5","author":"Manzo C","year":"2019","unstructured":"Manzo C, Milchert M, Natale M, Brzosko M. (2019). Polymyalgia rheumatica with normal values of both erythrocyte sedimentation rate and C-reactive protein concentration at the time of diagnosis Rheumatology (Oxford). 5: 921-923.","journal-title":"Rheumatology (Oxford)"},{"key":"ref-777097","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4081\/reumatismo.2018.1048","article-title":"Pathogenesis of polymyalgia rheumatica","volume":"70","author":"Guggino G","year":"2018","unstructured":"Guggino G, Ferrante A, Macaluso F, et al. (2018). Pathogenesis of polymyalgia rheumatica Reumatismo. 70: 10-17.","journal-title":"Reumatismo"},{"key":"ref-777098","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1001\/jama.1985.03360190069027","article-title":"Remitting seronegative symmetrical synovitis with pitting edema: RS3PE syndrome","volume":"254","author":"McCarty DJ","year":"1985","unstructured":"McCarty DJ, O\u2019 Duffy JD, Pearson L, et al. (1985). Remitting seronegative symmetrical synovitis with pitting edema: RS3PE syndrome JAMA. 254: 2763-2767.","journal-title":"JAMA"},{"key":"ref-777099","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11926-015-0525-0","article-title":"RS3PE: clinical and research development","volume":"17","author":"Li H","year":"2015","unstructured":"Li H, Altman RD, Yao Q. (2015). RS3PE: clinical and research development Curr Rheumatol Rep. 17: 49.","journal-title":"Curr Rheumatol Rep"},{"key":"ref-777100","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/ard.58.4.230","article-title":"Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study","volume":"58","author":"Cantini F","year":"1999","unstructured":"Cantini F, Salvarani C, Olivieri I, et al. (1999). Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study Ann Rheum Dis. 58: 230-236.","journal-title":"Ann Rheum Dis"},{"key":"ref-777101","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4081\/reumatismo.2018.1031","article-title":"The real evidence for polymyalgia rheumatica as a paraneoplastic syndrome","volume":"70","author":"Muller S","year":"2018","unstructured":"Muller S, Hider S, Helliwell T, et al. (2018). The real evidence for polymyalgia rheumatica as a paraneoplastic syndrome Reumatismo. 70: 23-34.","journal-title":"Reumatismo"},{"key":"ref-777102","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5770\/cgj.20.254","article-title":"Polymyalgia rheumatica in association with remitting seronegative synovitis with pitting edema: a neoplastic warning","volume":"20","author":"Manzo C","year":"2017","unstructured":"Manzo C, Natale M. (2017). Polymyalgia rheumatica in association with remitting seronegative synovitis with pitting edema: a neoplastic warning Can Geriatr J. 20: 94-96.","journal-title":"Can Geriatr J"},{"key":"ref-777103","doi-asserted-by":"crossref","first-page":"60","DOI":"10.12659\/AJCR.895717","article-title":"Association of Remitting Seronegative Symmetrical Synovitis with Pitting Edema, Polymyalgia Rheumatica, and Adenocarcinoma of the Prostate","volume":"17","author":"Emamifar A","year":"2016","unstructured":"Emamifar A, Hess S, Gildberg-Mortensen R, Jensen Hansen IM. (2016). Association of Remitting Seronegative Symmetrical Synovitis with Pitting Edema, Polymyalgia Rheumatica, and Adenocarcinoma of the Prostate Am J Case Rep. 17: 60-64.","journal-title":"Am J Case Rep"},{"key":"ref-777104","doi-asserted-by":"crossref","first-page":"e0160221","DOI":"10.1371\/journal.pone.0160221","article-title":"Adverse events associated with immune checkpoint blockade in patients with cancer: a systematic review of case reports","volume":"11","author":"Abdel-Wahab N","year":"2016","unstructured":"Abdel-Wahab N, Shah M, Suarez-Almazor ME. (2016). Adverse events associated with immune checkpoint blockade in patients with cancer: a systematic review of case reports PloS One. 11: e0160221.","journal-title":"PloS One"},{"key":"ref-777105","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2017-211216","article-title":"Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment","volume":"76","author":"Belkhir R","year":"2017","unstructured":"Belkhir R, Burel SL, Dunogeant L, et al. (2017). Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment Ann Rheum Dis. 76: 1747-1750.","journal-title":"Ann Rheum Dis"},{"key":"ref-777106","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.semarthrit.2017.03.003","article-title":"Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab","volume":"47","author":"Gauci ML","year":"2017","unstructured":"Gauci ML, Baroudjian B, Laly P, et al. (2017). Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab Semin Arthritis Rheum. 47: 281-287.","journal-title":"Semin Arthritis Rheum"},{"key":"ref-777107","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/BOR.0000000000000601","article-title":"Arthritis risk with immune checkpoint inhibitor therapy for cancer","volume":"31","author":"Pundole X","year":"2019","unstructured":"Pundole X, Abdel-Wahab N, Suarez-Almazor ME. (2019). Arthritis risk with immune checkpoint inhibitor therapy for cancer Curr Opin Rheumatol. 31: 293-299.","journal-title":"Curr Opin Rheumatol"},{"key":"ref-777108","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0049-0172(84)90012-X","article-title":"Long-term follow-up of polymyalgia rheumatica: evidence of synovitis","volume":"13","author":"Healey LA","year":"1984","unstructured":"Healey LA. (1984). Long-term follow-up of polymyalgia rheumatica: evidence of synovitis Semin Arthritis Rheum. 13: 322-328.","journal-title":"Semin Arthritis Rheum"},{"key":"ref-777109","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.urology.2005.12.014","article-title":"Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with superficial bladder cancer? A metaanalysis of randomized trials","volume":"67","author":"Han RF","year":"2006","unstructured":"Han RF, Pan JG. (2006). Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with superficial bladder cancer? A metaanalysis of randomized trials Urology. 67: 1216-1223.","journal-title":"Urology"},{"key":"ref-777110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jgo.2018.03.020","article-title":"The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients","volume":"9","author":"Racioppi M","year":"2018","unstructured":"Racioppi M, Di Gianfrancesco L, Ragonese M, et al. (2018). The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients J Ger Oncol. 9: 507-512.","journal-title":"J Ger Oncol"},{"key":"ref-777111","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0022-5347(17)45606-0","article-title":"Complications of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancer","volume":"135","author":"Lamm DL","year":"1986","unstructured":"Lamm DL, Stogdill VD, Stogdill BJ, Crispen RG. (1986). Complications of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancer J Urol. 135: 272-274.","journal-title":"J Urol"},{"key":"ref-777112","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.autrev.2013.06.017","article-title":"Reactive arthritis induced by intravesical BCG therapy for bladder cancer: our clinical experience and systematic review of the literature","volume":"12","author":"Bernini L","year":"2013","unstructured":"Bernini L, Manzini CU, Giuggioli D, et al. (2013). Reactive arthritis induced by intravesical BCG therapy for bladder cancer: our clinical experience and systematic review of the literature Autoimmun Rev. 12: 1150-1159.","journal-title":"Autoimmun Rev"},{"key":"ref-777113","first-page":"1699","article-title":"Remitting seronegative symmetrical synovitis with pitting edema following intravesical bacillus Calmette-Guerin instillation","volume":"28","author":"Mouly S","year":"2001","unstructured":"Mouly S, Berenbaum F, Kaplan G. (2001). Remitting seronegative symmetrical synovitis with pitting edema following intravesical bacillus Calmette-Guerin instillation J Rheumatol. 28: 1699-1701.","journal-title":"J Rheumatol"},{"key":"ref-777114","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s10067-005-0157-2","article-title":"Remitting seronegative symmetrical synovitis pitting oedema after BGC instillation","volume":"25","author":"El Mazhou","year":"2006","unstructured":"El Mazhou S, Popa L, Constantin A, et al. (2006). Remitting seronegative symmetrical synovitis pitting oedema after BGC instillation Clin Rheum. 25: 566-567.","journal-title":"Clin Rheum"},{"key":"ref-777115","first-page":"110","article-title":"Polymyalgia rheumatica with temporal arteritis following intravesical Calmette-Guerin bacillus immunotherapy for bladder cancer","volume":"14","author":"Genereau T","year":"1996","unstructured":"Genereau T, Koeger AC, Chaibi P, Bourgeois P. (1996). Polymyalgia rheumatica with temporal arteritis following intravesical Calmette-Guerin bacillus immunotherapy for bladder cancer Clin Exp Rheumatol. 14: 110.","journal-title":"Clin Exp Rheumatol"},{"key":"ref-777116","doi-asserted-by":"crossref","first-page":"A179","DOI":"10.1016\/j.revmed.2016.10.214","article-title":"Vascularites des gros vaisseaux induites par une prise m\u00e9dicamenteuse: 2 nouveaux cas secondaires \u00e0 l\u2019administration de BCG-th\u00e9rapie et de G-CSF","volume":"37","author":"Stavris C","year":"2016","unstructured":"Stavris C, Retornaz F, Charpin C, et al. (2016). Vascularites des gros vaisseaux induites par une prise m\u00e9dicamenteuse: 2 nouveaux cas secondaires \u00e0 l\u2019administration de BCG-th\u00e9rapie et de G-CSF Rev Med Int. 37: A179.","journal-title":"Rev Med Int"},{"key":"ref-777117","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/OARRR.S116036","article-title":"Polymyalgia rheumatica and cancer risk: the importance of the diagnostic set","volume":"8","author":"Manzo C","year":"2016","unstructured":"Manzo C, Natale M. (2016). Polymyalgia rheumatica and cancer risk: the importance of the diagnostic set Open Access Rheumatol. 8: 93-95.","journal-title":"Open Access Rheumatol"},{"key":"ref-777118","first-page":"506","article-title":"The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease","volume":"56","author":"Dejaco C","year":"2017","unstructured":"Dejaco C, Duftner C, Buttgereit F, et al. (2017). The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease Rheumatology (Oxford). 56: 506-515.","journal-title":"Rheumatology (Oxford)"},{"key":"ref-777119","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/ard.60.11.1058","article-title":"Subclinical vasculitis in polymyalgia rheumatica","volume":"60","author":"Marzo-Ortega H","year":"2001","unstructured":"Marzo-Ortega H, McGonagle D, O\u2019Connor P, et al. (2001). Subclinical vasculitis in polymyalgia rheumatica Ann Rheum Dis. 60: 1058-1059.","journal-title":"Ann Rheum Dis"},{"key":"ref-777120","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.3389\/fmicb.2017.01938","article-title":"Morbid sequences suggest molecular mimicry between microbial peptides and self-antigens: a possibility of inciting autoimmunity","volume":"8","author":"Pahari S","year":"2017","unstructured":"Pahari S, Deepyan Chatterjee D, Negi S, et al. (2017). Morbid sequences suggest molecular mimicry between microbial peptides and self-antigens: a possibility of inciting autoimmunity Front Microbiol. 8: 1938.","journal-title":"Front Microbiol"}],"container-title":["Rheumatology"],"original-title":[],"link":[{"URL":"https:\/\/reu.termedia.pl\/pdf-111321-85847","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/reu.termedia.pl\/pdf-111321-85847","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T08:08:56Z","timestamp":1674806936000},"score":1,"resource":{"primary":{"URL":"https:\/\/reu.termedia.pl\/Polymyalgia-rheumatica-and-remitting-seronegative-symmetrical-synovitis-with-pitting,111321,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,31]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"alternative-id":["111321"],"URL":"https:\/\/doi.org\/10.5114\/reum.2019.87617","relation":{},"ISSN":["0034-6233","2084-9834"],"issn-type":[{"value":"0034-6233","type":"print"},{"value":"2084-9834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,31]]}}}